Overview
Glycine is the simplest non-essential amino acid in the human body, yet its roles span far beyond basic protein structure. As the most abundant amino acid in collagen, glycine serves as a building block for skeletal integrity, skin elasticity, and connective tissue strength. Beyond its structural role, glycine functions as a multifunctional signaling molecule, influencing sleep quality, cognitive performance, metabolic health, and immune function through multiple biochemical pathways.
The compound is widely available in supplement form as a powder or capsule, typically ranging from $8–$25 per month. It is taken orally and has achieved FDA GRAS (Generally Recognized As Safe) status, making it one of the most well-tolerated amino acids available. Whether you're an athlete seeking joint support, an individual struggling with sleep quality, or someone interested in metabolic optimization, understanding glycine's evidence base and practical application is essential for making informed supplementation decisions.
How Glycine Works: Mechanisms of Action
Glycine exerts its effects through multiple biological pathways, making it a remarkably versatile compound.
Central Nervous System Effects
Glycine functions as an inhibitory neurotransmitter in the brainstem and spinal cord by binding to glycine receptors (GlyR), a class of strychnine-sensitive ion channels. When glycine binds to these receptors, it hyperpolarizes neurons, reducing their excitability and promoting relaxation and sleep onset. This mechanism explains much of glycine's popular use as a sleep support supplement.
Additionally, glycine acts as a co-agonist at NMDA glutamate receptors in the central nervous system. By modulating these receptors, glycine influences excitatory neurotransmission, affecting cognition, neuroprotection, and potentially supporting memory formation and learning processes.
Metabolic and Antioxidant Roles
Beyond neurotransmission, glycine serves as a critical substrate for multiple biosynthetic pathways:
- Glutathione synthesis: Glycine is one of three amino acids required to produce glutathione, the body's master antioxidant. Adequate glycine availability ensures robust antioxidant defenses.
- Creatine biosynthesis: Glycine participates in creatine production, supporting energy metabolism and ATP regeneration in muscles and the brain.
- Heme production: Glycine is essential for hemoglobin and myoglobin synthesis, supporting oxygen transport and utilization.
- Bile acid conjugation: Glycine conjugates with bile acids, facilitating fat digestion, cholesterol metabolism, and detoxification pathways.
These metabolic roles explain glycine's plausibility as a supplement for energy, liver health, and metabolic optimization.
Evidence by Health Goal
Sleep Quality
Evidence Tier: 3 (Probable)
Sleep is one of glycine's most well-studied applications, with consistent evidence supporting its efficacy for improving sleep architecture and reducing nighttime awakenings.
In one randomized controlled trial of 13 athletic males with sleep complaints, glycine-rich collagen peptides (15 g/day for 7 nights) reduced polysomnographic awakenings from 29.3±13.8 counts to 21.3±9.7 counts (P=0.028). The same study showed subjective sleep improvements, with reported awakenings decreasing from 1.9±0.6 to 1.3±1.5 counts (P=0.023).
A second human RCT in 16 healthy adults using a multi-ingredient formula containing glycine demonstrated reductions in sleep onset latency by 24±25 minutes (P=0.002), increased total sleep time by 22±32 minutes (P=0.01), and improved sleep efficiency by 2.4±3.9% (P=0.03).
While the evidence base is limited to 2–3 small trials, the consistency of findings supports glycine's probable efficacy for sleep fragmentation and latency reduction. The mechanism—glycine's binding to inhibitory glycine receptors—provides strong theoretical support.
Collagen Synthesis & Connective Tissue Health
Evidence Tier: 2 (Promising)
As the most abundant amino acid in collagen (comprising approximately 33% of collagen's amino acid content), glycine's role in structural tissue support is mechanistically sound. While human clinical trials directly measuring skin or joint outcomes are limited, animal and mechanistic evidence is compelling.
In lens-induced myopic guinea pigs, glycine supplementation significantly increased COL1A1 synthesis in scleral fibroblasts, reversing the collagen reduction seen in glycine-deficient animals. In human keratinocytes cultured in vitro, glycine supplementation increased ATP production and biomass, both critical markers for cell proliferation and migration during wound healing processes.
Animal studies of wound healing consistently demonstrate glycine's benefits. In traumatized mature rats, arginine plus glycine supplementation significantly increased nitrogen retention and enhanced the collagen type III/I ratio in wound sponges compared to controls, with mature rats showing greater benefits than aged animals.
Muscle Growth & Recovery
Evidence Tier: 2 (Promising)
Glycine supplementation shows plausible benefits for muscle growth through several mechanisms: ferroptosis resistance, creatine synthesis support, and collagen production. However, human efficacy data remains limited.
In a small RCT of 29 critically ill patients, high-dose glycine (0.4 g/kg/day) demonstrated dose-dependent increases in plasma glycine levels and trends toward improved quadriceps muscle thickness at day 7 compared to placebo, though statistical significance for muscle outcomes was not formally reported.
Animal evidence is more compelling. In aged mice (n=16), high-intensity interval training combined with glycine supplementation significantly increased maximum grip strength and myofiber cross-sectional area with reduced TUNEL-positive apoptotic cells—effects validated through ferroptosis pathway markers and RNA-sequencing analysis.
For athletic performance specifically, one human RCT of 23 marathon runners found that 30 g/day glycine for 14 days did not reduce extremity pain or gastrointestinal symptoms compared to placebo during marathon competition, suggesting limited acute performance-enhancing effects in trained athletes under intense exertion.
Cognitive Function & Memory
Evidence Tier: 2 (Promising)
Glycine's role as an NMDA co-agonist suggests potential cognitive benefits, supported by limited human evidence.
One double-blind RCT demonstrated that glycine-rich collagen peptides improved Stroop test accuracy (1.00 vs 0.97, P=0.009) in physically active males with sleep complaints. A separate crossover RCT found that biologically active glycine significantly improved episodic memory retrieval in both young (mean age 20.7 years) and middle-aged (mean age 58.9 years) adults, though specific P-values were not provided.
Notably, another trial found that glycine improved episodic memory in both age groups but did not significantly affect mood measures, suggesting its cognitive benefits may be domain-specific to memory function rather than broad mood effects.
Metabolic Health & Fat Loss
Evidence Tier: 3 (Probable)
Glycine supplementation shows promise for improving metabolic markers related to fat loss, particularly triglyceride reduction and mitochondrial fuel oxidation, though direct body weight or fat mass reduction has not been consistently demonstrated in humans.
In a small RCT of 19 severely obese adults, 100 mg/kg/day glycine supplementation for 2 weeks significantly reduced plasma triglycerides with no change in body weight. The same study demonstrated improvements in the glutamate-serine-glycine index, a marker of metabolic dysfunction-associated fatty liver disease.
In 8 HIV patients (open-label, 14 days), glycine plus cysteine supplementation improved both fasted and fed mitochondrial fuel oxidation, enhanced insulin sensitivity, and improved body composition markers in a GSH-deficient population.
Observational evidence supports glycine's metabolic role: individuals with obesity showed significantly lower baseline plasma glycine (168±30 vs. 209±50 μmol/L in healthy controls) and reduced acylglycine synthesis rates, indicating impaired detoxification capacity.
Heart Health
Evidence Tier: 3 (Probable)
Large observational studies suggest glycine's cardiovascular benefits, though mechanistic RCTs in human populations are limited.
A massive meta-analysis of 105,718 UK Biobank subjects found that elevated serum glycine was associated with a 30% reduced incident coronary artery disease risk (HR=0.70, 95% CI 0.65-0.77, P<0.0001) after multivariable adjustment—a finding suggesting strong cardiovascular benefit, though causality remains incompletely established.
Animal evidence consistently supports this observation. In apolipoprotein E-deficient mice, glycine supplementation significantly attenuated atherosclerosis development, while glycine deficiency enhanced it. A glycine-based compound reduced aortic atherosclerosis and superoxide production in these disease models.
Liver Health
Evidence Tier: 3 (Probable)
Glycine supplementation shows probable benefits for liver health, particularly for reducing liver enzyme markers and improving metabolic dysfunction-associated fatty liver disease indices.
In a small RCT of 19 humans with severe obesity (2 weeks), 100 mg/kg/day glycine supplementation significantly reduced plasma aminotransferases and improved the glutamate-serine-glycine index (a key MASLD marker) with no changes in body weight.
Animal studies consistently demonstrate mechanisms involving glutathione synthesis and detoxification pathways, supporting glycine's role in hepatic protection and metabolic health.
Longevity & Oxidative Stress
Evidence Tier: 3 (Probable)
Glycine supplementation extends lifespan in animal models and likely improves longevity-related markers in humans through glutathione synthesis and oxidative stress reduction, though large human RCTs demonstrating clinical longevity benefit remain absent.
In mice, glycine supplementation extended lifespan by 4–6% across three independent testing sites (P=0.002 in males, P<0.001 in females) with increased maximum lifespan.
In elderly humans (n=8), 2 weeks of glycine plus cysteine supplementation increased red blood cell glutathione concentration by 94.6% and reduced plasma F2-isoprostanes (oxidative damage markers), demonstrating direct antioxidant benefits in human subjects.
Anti-Inflammatory Effects
Evidence Tier: 3 (Probable)
Glycine shows probable anti-inflammatory effects in humans based on mechanistic studies and animal evidence, though high-quality human RCTs remain sparse.
In rodent models of lead toxicity, glycine (500–1000 mg/kg) significantly reduced serum inflammatory markers and renal tissue oxidative stress biomarkers (P<0.001) while preventing histopathological inflammation.
In dystrophic mice, glycine supplementation reduced diaphragm fibrotic deposition by 22% over 14 weeks (P<0.02) and augmented prednisolone's anti-inflammatory effects by an additional 23%.
Gut Health & Intestinal Integrity
Evidence Tier: 2 (Promising)
Glycine shows plausible benefits for gut health through animal studies and mechanistic research, though human evidence for direct gut health benefits remains limited.
In broilers exposed to heat stress, glycine supplementation (0.5–2.0%) prevented reduction in intestinal tight junction protein expression (Occludin, ZO-1) and reduced intestinal permeability compared to heat-stressed controls.
Zinc-glycine supplementation in geese increased the abundance of Firmicutes and short-chain fatty acid-producing bacteria, upregulated tight junction proteins (ZO-1, Claudin-1), and reduced intestinal permeability and inflammatory cytokines in serum and cecum.
Immune Support
Evidence Tier: 2 (Promising)
Glycine shows immunomodulatory potential in animal models, but human evidence for direct immune benefits is extremely limited. One small open-label study (n=8 HIV patients) found that 14 days of glycine plus cysteine supplementation restored impaired glutathione synthesis and improved mitochondrial fuel oxidation, with associated gains in muscle strength, though direct immune outcomes were not formally measured.
Athletic Performance & Injury Recovery
Evidence Tier: 2 (Promising) for Injury Recovery; Tier 2 (Promising) for Performance
For injury recovery, glycine shows plausible benefits based on consistent animal evidence demonstrating collagen synthesis enhancement and wound healing support. However, no human RCTs or clinical trials have directly tested glycine's efficacy in injured athletic populations.
For acute athletic performance, the evidence is less compelling. The marathon study (n=23) showed null results, suggesting glycine may not provide acute performance benefits during intense competition, though benefits for recovery and chronic adaptations remain possible.
Skin & Hair Health
Evidence Tier: 2 (Promising)
Glycine shows plausible benefits for skin and hair health based on its critical role in collagen synthesis, though human efficacy for these specific outcomes remains unproven. In human keratinocytes in vitro, glycine increased ATP production and biomass, both critical for cell proliferation and migration in wound healing. Animal studies confirm enhanced collagen synthesis with glycine supplementation.
Hormonal Balance & Sexual Health
Evidence Tier: 2 (Hormonal); Tier 1 (Sexual Health)
Glycine has been studied primarily in animal models for hormonal outcomes, with suggestive but unproven efficacy. The only direct human evidence (n=13) shows improvements in sleep quality and cognitive function but does not demonstrate clear hormonal effects.
For sexual health, glycine has not been directly studied in humans. The evidence consists of one case report of sarcosine (a glycine derivative) that incidentally increased libido, and studies on soy isoflavones (from the Glycine max plant) that improved sexual symptoms in menopausal women—but these do not isolate glycine as the active ingredient.
Mood & Stress
Evidence Tier: 2 (Promising but Unproven)
Glycine has been studied for mood and stress primarily in animal models. Only one small human RCT (n=19) directly addresses glycine supplementation, showing metabolic effects but not specifically measuring mood or stress outcomes. One study found that glycine did not significantly affect mood measures despite improving memory. A separate study involving NAD+ infusions containing glycine and other amino acids reduced self-reported anxiety and depression in 50 substance use disorder patients, but glycine's isolated contribution cannot be determined.